Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 1 (PIP5K1P1, also known as MGC26597) is classified as a pseudogene in the human genome. Unlike its functional relatives (such as PIP5K1A, PIP5K1B, and PIP5K1C), which are active kinases involved in phosphoinositide signaling, PIP5K1P1 does not encode a protein and has no known enzymatic or receptor activity. It is not associated with therapeutic targeting, biological function, interaction with drugs, nor does it serve as a biomarker or present therapeutic safety concerns. Its clinical and research relevance is minimal due to the lack of coding potential, and it may occasionally cause confusion with genuine kinase targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 1 (PIP5K1P1).